In a letter calling for a congressional investigation, Rep. Waxman provides examples of how proliferating information designations such as "sensitive but unclassified" have been used to block the release of important government records.
A new report released by Reps. Waxman and other senior members of Congress details how the Social Security Administration has systematically altered its public communications.
In a letter to Chairman Davis, Rep. Waxman asks for congressional hearings into the allegations of steroid use in Major League Baseball and the adequacy of the league's response.
Reps. Waxman and Meehan write to Attorney General Gonzales to express their support for the Justice Department's aggressive pursuit of the landmark case against the tobacco industry.
The Comptroller General writes to all executive branch agency heads to advise them of the restrictions on spending for "publicity and propaganda," specifically noting the GAO's finding that some prepackaged news stories are illegal covert propaganda.
In letters to Secretary of State Rice and USAID Administrator Natsios, Reps. Waxman and Cummings clarify the International Narcotics Control Board's position on the efficacy of needle exchange programs. Chairmen Davis and Souder had mischaracterized the report in previous correspondence.
Rep. Waxman asks for a full explanation of the role of Ambassador Dick Jones, Secretary of State Rice's choice to head U.S. Iraq policy, in the steering of a lucrative fuel contract to an obscure Kuwaiti company.
Rep. Waxman and 18 other member of Congress urge the Department of Labor to continue the National Agricultural Workers Survey, which provides essential information on employment, immigration, health, public benefits, education, wages, and income.
Reps. Waxman and Gordon introduce H.R. 839, legislation to protect federal science from political interference. The bill includes bars on manipulating science, suppressing research, and using political litmus tests to appoint members of scientific advisory committees.
Rep. Waxman expresses concerns to FDA Acting Commissioner Dr. Lester Crawford that budget cuts proposed by the President will reduce the number of FDA employees and hamper already-faltering enforcement efforts.
There has been a sharp decline in FDA enforcement actions against misleading drug advertisements and violations of manufacturing standards by biologic drug companies since Dr. Lestor Crawford was appointed as Acting Commissioner in early 2002.
A politically well connected organization that promotes abstinence education has received a major federal grant under the President’s AIDS program despite its proposal having been rated “not suitable for funding” by an independent review panel.
At a Senate Democratic Policy Committee hearing, a former Coalition Provisional Authority official and other whistleblowers testify on the waste, fraud, and abuse of Iraqi funds under the stewardship of the Bush Administration.
Reps. Waxman and Maloney ask for hearings on whether political considerations caused the Administration to delay release of findings by the 9/11 Commission about pre-attack warnings.
Reps. Waxman and Rahall write Interior Secretary Norton about new survey results that describe pervasive politicization of FWS’s scientific mission.
Rep. Waxman, Sen. Akaka and Rep. Danny Davis express serious concerns about a Defense Department plan to give higher raises to political appointees than to career employees.
Rep. Waxman asks Chairman Davis to amend the Committee's oversight plan to include consideration of the treatment of detainees, the use of covert propaganda, the politicization of science, conflicts of interest, the rise in government secrecy, and other important issues that Congress has failed to address.
Democratic Whip Hoyer, Rep. Waxman, and seven other Democratic members of Congress object to the Administration's plan to expand the elimination of civil service protections from the Departments of Defense and Homeland Security to the rest of the federal government.
Citing the failure of the Consumer Product Safety Commission to protect children from hazardous levels of lead in consumer products, Rep. Waxman announces plans to introduce legislation to ban lead from toys, toy jewelry, and other items for children under age six.
Rep. Waxman and other members of Congress seek more information about recent management decisions made by the Office of Special Counsel, including a decision to require a dozen senior DC-based employees to transfer to field offices.
In a letter to Government Reform Committee Chairman Davis, Reps. Waxman and Lantos request investigative hearings on the Administration’s mismanagement of nearly $9 billion from the Development Fund for Iraq.
The House Democratic leadership and ranking Democratic members ask the President to direct the release of all contracts for secret publicity campaigns to promote administration policies.
Citing a new GAO report, Sen. Kennedy and Rep. Waxman urge the President not to squander the historic opportunity to use inexpensive, safe, and effective drugs to fight the epidemic in the developing world.
A new report finds that the Bush Administration spent a record $88 million on government-funded public relations contracts in 2004, a 128% increase since 2000.
Rep. Waxman releases a report finding that over half of California’s juvenile detention facilities inappropriately incarcerate youth waiting for mental health treatment.
Displaying Items 901 to 925 of 1458:
[1] • [2] • [3] • [4] • [5] • [6] • [7] • [8] • [9] • [10] • [11] • [12] • [13] • [14] • [15] • [16] • [17] • [18] • [19] • [20] • [21] • [22] • [23] • [24] • [25] • [26] • [27] • [28] • [29] • [30] • [31] • [32] • [33] • [34] • [35] • [36] • [37] • [38] • [39] • [40] • [41] • [42] • [43] • [44] • [45] • [46] • [47] • [48] • [49] • [50] • [51] • [52] • [53] • [54] • [55] • [56] • [57] • [58] • [59]